LMU-Campus Grosshadern

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease3 trials
• Crohn's disease1 trial
• Ulcerative colitis1 trial

Phase

• Phase 2/33 trials
• Phase 31 trial

Status

• Not yet recruiting2 trials
• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Washington University School of Medicine3 trials
• Takeda1 trial

Running trials

• Recruiting

  A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  NCT05552157· Phase 2/3· Washington University School of Medicine· Source

  Contact: Johannes Levin, M.D, (principal investigator)

• Recruiting

  A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  NCT06647498· Phase 2/3· Washington University School of Medicine· Source

  Contact: Johannes Levin, M.D, (principal investigator)

• Active, not recruiting

  Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)

  NCT05269394· Phase 2/3· Washington University School of Medicine· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease2 recruiting

Closed trials

• Completed

  A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

  NCT02620046· Phase 3· Takeda· Source